Vertex Pharmaceuticals
VRTXVertex Pharmaceuticals is a global biotechnology company dedicated to developing transformative medicines for serious diseases with a focus on specialty markets.
Earnings
Next report
Nov 2, 2026 (in 2 months)Financials
Q2 2026Valuation & ratios
Segments
By product
Competitors
By market cap
By revenue growth
By net margin
Profile
Vertex Pharmaceuticals is a global biotechnology company dedicated to developing transformative medicines for serious diseases with a focus on specialty markets. The company leverages a serial innovation strategy to discover and commercialize therapies that address the underlying causes of diseases such as cystic fibrosis, sickle cell disease, and acute pain. Their approach combines deep human biology insights with advanced therapeutic modalities to deliver first-in-class and best-in-class treatments.
Vertex is the dominant leader in the cystic fibrosis market and a pioneer in CRISPR-based gene editing and non-opioid pain treatments.
FAQ
- What is Vertex Pharmaceuticals's market cap?
- Vertex Pharmaceuticals (VRTX) has a market capitalization of $138.72B and trades on NASDAQ.
- What is Vertex Pharmaceuticals's revenue and profitability?
- Vertex Pharmaceuticals generated $12.6B in trailing twelve-month revenue with net income of $4.4B, representing a net margin of 35.0%. Gross margin stands at 86.0%. These figures are based on the Q2 2026 filing.
- Who are Vertex Pharmaceuticals's competitors?
- Vertex Pharmaceuticals's key competitors include AbbVie, Fulcrum Therapeutics, Inc. Common Stock, Sionna Therapeutics, Inc. Common Stock, and others. These companies compete in similar markets and product categories.
- Who does Vertex Pharmaceuticals partner with?
- Vertex Pharmaceuticals's notable partners include CRISPR Therapeutics.
- What subsidiaries does Vertex Pharmaceuticals have?
- Vertex Pharmaceuticals's subsidiaries include Alpine Immune Sciences.
- Where is Vertex Pharmaceuticals headquartered?
- Vertex Pharmaceuticals is headquartered in United States of America and employs approximately 5,400 people. It has been publicly traded since 1991.
